EIF4E and ovarian carcinoma: Importantly, our study demonstrates that inhibiting EV secretion reduces PD‐L1 expression on TAMs in ovarian tumor bearing mice, highlighting the role of eIF4E in modulating PD‐L1 expression and influencing metastasis in ovarian cancer.